Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04QYN
|
|||
| Former ID |
DNC014397
|
|||
| Drug Name |
5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione
|
|||
| Synonyms |
15264-63-8; 5-(4-Pyridyl)-1,3,4-oxadiazole-2-thiol; 5-(pyridin-4-yl)-1,3,4-oxadiazole-2-thiol; 5-pyridin-4-yl-[1,3,4]oxadiazole-2-thiol; 5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione; CHEMBL571513; 5-pyridin-4-yl-1,3,4-oxadiazole-2-thiol; 5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol; TXCXZVFDWQYTIC-UHFFFAOYSA-N; 1,3,4-Oxadiazole-2(3H)-thione,5-(4-pyridinyl)-; 1,3,4-Oxadiazole-2-thiol, 5-(4-pyridinyl)-; ZERO/005315; AC1LGNJA; ChemDiv2_000174; AC1Q7F3J; Oprea1_812023; Oprea1_290121; SCHEMBL987340; SCHEMBL17065364; CTK4C7526
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H5N3OS
|
|||
| Canonical SMILES |
C1=CN=CC=C1C2=NNC(=S)O2
|
|||
| InChI |
1S/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12)
|
|||
| InChIKey |
TXCXZVFDWQYTIC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 15264-63-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
| BioCyc | (S)-reticuline biosynthesis | |||
| Eumelanin biosynthesis | ||||
| L-dopachrome biosynthesis | ||||
| KEGG Pathway | Tyrosine metabolism | |||
| Riboflavin metabolism | ||||
| Metabolic pathways | ||||
| Melanogenesis | ||||
| Pathwhiz Pathway | Riboflavin Metabolism | |||
| Tyrosine Metabolism | ||||
| WikiPathways | Dopamine metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triaz... Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.